Content
05/23/2024
Berkeley, CA USA
Radar Therapeutics
completed $13.4 million Seed Round funding. Investors include
NfX (lead), KdT Ventures, Eli Lilly and Company, Biovision Ventures, BEVC, Pear VC.
About
Radar Therapeutics is a biotech company developing programmable
precision therapeutics. Leveraging innovative mRNA technology and
proprietary regulatory control elements, the company aims to
revolutionize medicine by enabling targeted, timely, and controlled
therapeutic interventions. Radar is committed to advancing the
boundaries of genetic medicine to address unmet medical needs and
improve patient access.
Startup
Sector:
Biotech
Healthcare
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
